Lantheus Announces Presentation of Data at ASCO 2026
Lantheus Holdings, Inc. announced that it will present data at the 2026 American Society of Clinical Oncology Annual Meeting, highlighting its commitment to improving patient outcomes through radiopharmaceuticals.
BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced data to be featured at the 2026